000 | 01149 a2200313 4500 | ||
---|---|---|---|
005 | 20250516033251.0 | ||
264 | 0 | _c20110621 | |
008 | 201106s 0 0 eng d | ||
022 | _a1528-4336 | ||
024 | 7 |
_a10.1310/hct1202-118 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWen, Ying | |
245 | 0 | 0 |
_aInterferon successfully inhibited refractory cytomegalovirus infection and resulted in CD4+ T-cells increase in a patient with AIDS. _h[electronic resource] |
260 |
_bHIV clinical trials _c |
||
300 |
_a118-20 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Letter | ||
650 | 0 | 4 |
_aAIDS-Related Opportunistic Infections _xdrug therapy |
650 | 0 | 4 | _aAntiretroviral Therapy, Highly Active |
650 | 0 | 4 | _aCD4 Lymphocyte Count |
650 | 0 | 4 |
_aCytomegalovirus Infections _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInterferon alpha-2 |
650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aRecombinant Proteins |
700 | 1 | _aLiu, Pei | |
773 | 0 |
_tHIV clinical trials _gvol. 12 _gno. 2 _gp. 118-20 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1310/hct1202-118 _zAvailable from publisher's website |
999 |
_c20764091 _d20764091 |